Literature DB >> 35296110

Cyclophilin D regulation of the mitochondrial permeability transition pore.

Elizabeth Murphy1.   

Abstract

The opening of the mitochondrial permeability transition pore (PTP) has been proposed to play a critical role in activating cell death in many settings, including cardiac ischemia and reperfusion. Although the identity of pore forming unit of the PTP is still debated, it is generally agreed that cyclophilin D (CyPD) is a regulator of the PTP. This manuscript will focus on understanding how CyPD might regulate the PTP and how understanding CyPD might give insight about the identify and regulation of the PTP.

Entities:  

Year:  2022        PMID: 35296110      PMCID: PMC8920311          DOI: 10.1016/j.cophys.2022.100486

Source DB:  PubMed          Journal:  Curr Opin Physiol        ISSN: 2468-8673


  43 in total

1.  Modulation of F0F1-ATP synthase activity by cyclophilin D regulates matrix adenine nucleotide levels.

Authors:  Christos Chinopoulos; Csaba Konràd; Gergely Kiss; Eugeniy Metelkin; Beata Töröcsik; Steven F Zhang; Anatoly A Starkov
Journal:  FEBS J       Date:  2011-02-23       Impact factor: 5.542

2.  Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death.

Authors:  Christopher P Baines; Robert A Kaiser; Nicole H Purcell; N Scott Blair; Hanna Osinska; Michael A Hambleton; Eric W Brunskill; M Richard Sayen; Roberta A Gottlieb; Gerald W Dorn; Jeffrey Robbins; Jeffery D Molkentin
Journal:  Nature       Date:  2005-03-31       Impact factor: 49.962

3.  Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death.

Authors:  Takashi Nakagawa; Shigeomi Shimizu; Tetsuya Watanabe; Osamu Yamaguchi; Kinya Otsu; Hirotaka Yamagata; Hidenori Inohara; Takeshi Kubo; Yoshihide Tsujimoto
Journal:  Nature       Date:  2005-03-31       Impact factor: 49.962

4.  Cysteine 202 of cyclophilin D is a site of multiple post-translational modifications and plays a role in cardioprotection.

Authors:  Georgios Amanakis; Junhui Sun; Maria M Fergusson; Shane McGinty; Chengyu Liu; Jeffery D Molkentin; Elizabeth Murphy
Journal:  Cardiovasc Res       Date:  2021-01-01       Impact factor: 10.787

5.  Persistence of the permeability transition pore in human mitochondria devoid of an assembled ATP synthase.

Authors:  Joe Carroll; Jiuya He; Shujing Ding; Ian M Fearnley; John E Walker
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-18       Impact factor: 11.205

6.  Enhancement of anxiety, facilitation of avoidance behavior, and occurrence of adult-onset obesity in mice lacking mitochondrial cyclophilin D.

Authors:  S Luvisetto; E Basso; V Petronilli; P Bernardi; M Forte
Journal:  Neuroscience       Date:  2008-06-21       Impact factor: 3.590

7.  Cyclophilin-D binds strongly to complexes of the voltage-dependent anion channel and the adenine nucleotide translocase to form the permeability transition pore.

Authors:  M Crompton; S Virji; J M Ward
Journal:  Eur J Biochem       Date:  1998-12-01

Review 8.  The adenine nucleotide translocase: a central component of the mitochondrial permeability transition pore and key player in cell death.

Authors:  Andrew P Halestrap; Catherine Brenner
Journal:  Curr Med Chem       Date:  2003-08       Impact factor: 4.530

9.  The Unique Cysteine of F-ATP Synthase OSCP Subunit Participates in Modulation of the Permeability Transition Pore.

Authors:  Michela Carraro; Kristen Jones; Geppo Sartori; Marco Schiavone; Salvatore Antonucci; Roza Kucharczyk; Jean-Paul di Rago; Cinzia Franchin; Giorgio Arrigoni; Michael Forte; Paolo Bernardi
Journal:  Cell Rep       Date:  2020-09-01       Impact factor: 9.423

10.  ATP Synthase C-Subunit-Deficient Mitochondria Have a Small Cyclosporine A-Sensitive Channel, but Lack the Permeability Transition Pore.

Authors:  Maria A Neginskaya; Maria E Solesio; Elena V Berezhnaya; Giuseppe F Amodeo; Nelli Mnatsakanyan; Elizabeth A Jonas; Evgeny V Pavlov
Journal:  Cell Rep       Date:  2019-01-02       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.